EUVIMEDEUVIMED entdecken
Leitlinie

Revised guidelines for Australian laboratories performing mycobacteriology testing

Ivan Bastian, Lisa Shephard, Richard Lumb, National Tuberculosis Advisory Committee

Communicable Diseases Intelligence · 27.07.2021 · 44

DOI: 10.33321/cdi.2020.44.2 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Communicable Diseases Intelligence, online erschienen am 27.07.2021. Verfasst von Ivan Bastian und 3 weiteren Autor:innen. Beteiligte Einrichtung: SA Pathology, PO Box 14, Rundle Mall, Adelaide SA 5000. Hauptthemen laut MEDLINE: Practice Guidelines as Topic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 75 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycobacteriology laboratories play a key role in tuberculosis (TB) control by providing phenotypic and molecular diagnostics, by performing molecular typing to aid contact tracing, and by supporting research and similar laboratories in Australia’s neighbouring countries where TB is prevalent. The National Tuberculosis Advisory Committee (NTAC) published a set of laboratory guidelines in 2006 aiming to document the infrastructure, equipment, staffing and work practices required for safe high-quality work in Australian mycobacteriology laboratories. These revised guidelines have the same aims and have been through a similar extensive consultative peer-review process involving the Mycobacterium Reference Laboratory (MRL) network, the Mycobacterium Special Interest Group (SIG) of the Australian Society for Microbiology (ASM), and other relevant national bodies. This revised document contains several significant changes reflecting the publication of new biosafety guidelines and tuberculosis standards by various national and international organisations, technology developments – such as the MPT64-based immunochromatographic tests (ICTs) and the Xpert MTB/RIF assay, and updated work practices in mycobacteriology laboratories. The biosafety recommendations affirm the latest Australian/New Zealand Standard 2243.3: 2010 and promote a biorisk assessment approach that, in addition to the risk categorisation of the organism, also considers the characteristics of the procedure being performed. Using this biorisk assessment approach, limited manipulations, such as Ziehl-Neelsen (ZN) microscopy, MPT64 ICTs, and culture inactivation/DNA extraction for molecular testing, may be performed on a positive TB culture in a PC2 laboratory with additional features and work practices. Other significant changes include recommendations on the integration of MPT64 ICTs and novel molecular tests into TB laboratory workflows to provide rapid accurate results that improve the care of TB patients. This revised document supersedes the original 2006 publication. NTAC will periodically review these guidelines and provide updates as new laboratory technologies become available. (Last updated 29 April 2021.)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Practice Guidelines as TopicAustraliaHumansLaboratoriesMycobacterium tuberculosisTuberculosis

Autor:innen und Institutionen

  • SA Pathology, PO Box 14, Rundle Mall, Adelaide SA 5000.

Zitieren

APA

Bastian, I., Shephard, L., Lumb, R., & National Tuberculosis Advisory Committee (2021). Revised guidelines for Australian laboratories performing mycobacteriology testing. Communicable Diseases Intelligence, 44. https://doi.org/10.33321/cdi.2020.44.2

Vancouver

Bastian I, Shephard L, Lumb R, National Tuberculosis Advisory Committee. Revised guidelines for Australian laboratories performing mycobacteriology testing. Communicable Diseases Intelligence. 2021;44. doi:10.33321/cdi.2020.44.2

BibTeX
@article{Bastian2021,
  author = {Bastian, Ivan and Shephard, Lisa and Lumb, Richard and National Tuberculosis Advisory Committee, National Tuberculosis Advisory Committee},
  title = {Revised guidelines for Australian laboratories performing mycobacteriology testing},
  journal = {Communicable Diseases Intelligence},
  year = {2021},
  volume = {44},
  doi = {10.33321/cdi.2020.44.2}
}
Kostenlos starten →